CIK: 0001839209 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $284,152 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | AMBRX BIOPHARMA INC | 16,688,636 | $191,919 | 67.5% | $8.33 | — | SPONSORED ADS | 02290A102 |
| IMVT | IMMUNOVANT INC | 1,818,371 | $69,807 | 24.6% | $22.60 | 0.0% | COM | 45258J102 |
| ARGX | ARGENX SE | 45,615 | $22,426 | 7.9% | $378.83 | — | SPONSORED ADR | 04016X101 |